Li Xiaodong, Yin Xuedong, Bao Heyi, Liu Chang
Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Department of General Surgery, Qiqihar First Hospital, Qiqihar, 161005, China.
Mol Cell Probes. 2023 Feb;67:101877. doi: 10.1016/j.mcp.2022.101877. Epub 2022 Nov 25.
Sorafenib-resistance leads to poor prognosis and high mortality in advanced hepatocellular carcinoma (HCC), and this study aims to investigate the functional role of a circular RNA ITCH (circITCH) in regulating the sorafenib-resistance of HCC and its underlying mechanisms.
The expression of circITCH in HCC tissues and cell lines were detected by performing quantitative real-time polymerase chain reaction. Sorafenib-resistant HCC cells were transfected with PLCDH-circITCH to upregulate circITCH and intervened with sorafenib, and MTT assay, flow cytometry and transwell assay were used to test the cell viability, apoptosis and migration ability, respectively. The downstream target of circITCH were explored by using bioinformatic analysis, dual luciferase reporter system and Western blot.
CircITCH was significantly down-regulated in HCC tissues and cell lines, compared with their normal counterparts. Especially, in contrast with the sorafenib-sensitive HCC cells, continuous sorafenib treatment decreased the expression levels of circITCH in the sorafenib-resistant HCC cells. Overexpression of circITCH increased sorafenib-sensitivity, promoted cell apoptosis and reduced cell migration abilities in the sorafenib-resistant HCC cells. Mechanically, circITCH elevated PTEN expression to inactivate the PI3K/Akt signals through negatively regulating miR-20b-5p in HCC, and upregulating miR-20b-5p or inhibiting PTEN abolished the enhancing effect of circITCH overexpression on sorafenib-induced cytotoxicity in sorafenib-resistant HCC cells.
Taken together, this study proves that circITCH enhances sorafenib-sensitivity in sorafenib-resistant HCC cells via regulating the miR-20b-5p/PTEN/PI3K/Akt signaling cascade, which highlights the potential value of circITCH as a target for enhancing the sorafenib-sensitivity in HCC.
索拉非尼耐药导致晚期肝细胞癌(HCC)预后不良和高死亡率,本研究旨在探讨环状RNA ITCH(circITCH)在调节HCC索拉非尼耐药中的功能作用及其潜在机制。
通过定量实时聚合酶链反应检测HCC组织和细胞系中circITCH的表达。用PLCDH-circITCH转染索拉非尼耐药的HCC细胞以上调circITCH,并给予索拉非尼干预,分别用MTT法、流式细胞术和Transwell法检测细胞活力、凋亡和迁移能力。通过生物信息学分析、双荧光素酶报告系统和蛋白质免疫印迹法探索circITCH的下游靶点。
与正常组织和细胞相比,circITCH在HCC组织和细胞系中显著下调。特别是,与索拉非尼敏感的HCC细胞相比,持续索拉非尼处理降低了索拉非尼耐药的HCC细胞中circITCH的表达水平。circITCH过表达增加了索拉非尼耐药的HCC细胞对索拉非尼的敏感性,促进了细胞凋亡并降低了细胞迁移能力。机制上,circITCH通过在HCC中负向调节miR-20b-5p来提高PTEN表达,从而使PI3K/Akt信号失活,而上调miR-20b-5p或抑制PTEN则消除了circITCH过表达对索拉非尼耐药的HCC细胞中索拉非尼诱导的细胞毒性的增强作用。
综上所述,本研究证明circITCH通过调节miR-20b-5p/PTEN/PI3K/Akt信号级联增强了索拉非尼耐药的HCC细胞对索拉非尼的敏感性,这突出了circITCH作为增强HCC对索拉非尼敏感性靶点的潜在价值。